Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats. Orignial Source: https://www.foxbusiness.com/retail/hims-hers-responds-fda-pressure-pulls-knockoff-wegovy-drug-launch-after-regulatory-threats Previous article: BMW recalls nearly 90,000 vehicles over engine starter fire risk Prev Next article: Super Bowl ads see Bradley Cooper, Matthew McConaughey going head-to-head while Lady Gaga sings her heart out Next
